Hhcefi 100 Dry Syrup contains Cefixime 100mg/5ml, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, pharyngitis, tonsillitis, and uncomplicated gonorrhea caused by susceptible strains of bacteria. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The dry syrup formulation is reconstituted with water prior to administration, providing a convenient oral dosage form suitable for pediatric and adult patients who have difficulty swallowing tablets. Hhcefi 100 Dry Syrup should be used according to the prescribed dosage regimen, typically administered twice daily, with or without food. It is important to complete the full course of therapy to prevent the development of antibiotic resistance. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, while hypersensitivity reactions are rare but possible. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Renal function should be monitored in patients with impaired kidney function, as dosage adjustment may be necessary. Hhcefi 100 Dry Syrup is a valuable antimicrobial agent for managing bacterial infections when used appropriately under medical supervision.